BRCA1 and breast cancer: The prognostic significance of THRβ in patients carrying a BRCA1 mutation and in patients with sporadic BC was determined by Heublein et al. Results demonstrated that THRβ was more frequently expressed in BRCA1-associated BC compared to sporadic BC.